17-Jun-2020 | Facts and Factors
Findings from Facts and Factors report “Varicella Virus Vaccine Market By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and Others), and By Distribution Channel (Hospital, Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global varicella virus vaccine market in 2019 was approximately USD 711 million. The market is expected to grow above a CAGR of 4.8% and is anticipated to reach over USD 1,020 million by 2026.
Vaccines for varicella include a modified form of varicella-zoster virus. Such injections help to develop resistance to varicella-zoster disease because the infection can cause serious diseases such as herpes zoster and varicella.
Browse the full “Varicella Virus Vaccine Market By Drug Class (Quinine, Chloroquine, Proguanil, Mefloquine, Pyrimethamine, and Others), and By Distribution Channel (Hospital, Pharmacy, Retail Pharmacy, E-Commerce, and Other Distribution Channel): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/varicella-virus-vaccine-market-by-drug-class-quinine-1187
The main drivers of growing growth across the world market for live vaccines for varicella are increased awareness of the use of live vaccines for varicella and increased recognition of live vaccines for varicella. Successful policy policies and ongoing immunization measures would fuel the development of live vaccines for varicella on both markets. Recent developments in the acceptance of live vaccines for varicella have taken place around the world. That's because of the common, simple availability of these vaccines.
Improved immunization campaigns worldwide, increased awareness of the use of live vaccines for varicella, and increased acceptance of live vaccines for varicella are key factors in increasing global demand for live varicella. High government inputs aligned with output, on either side, somehow constrains growth. However, strong growth opportunities within developing economies have laid the foundation for a variety of opportunities within the industry.
By drug class, Chloroquine dominated the market in 2019 owing to its high effectiveness on the marlaria parasites and the ease of availibity of this drug. Based on distribution channel, hospital pharmacy led th market in the year 2019, this surge in this segment is primarily attributable to the increaser in the number of hospitals globally.
North America continues to dominate the global market for the treatment of malaria. The Asia Pacific market is expected to rise at a faster rate of growth as a result of increased awareness among people, increased investment in R&D, the use of skilled labor to produce products and increased investment by the pharmaceutical industry.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 711 Million |
Projected Market Size in 2026 |
USD 1,020 Million |
CAGR Growth Rate |
4.8% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Merck KGaA, Alvizia Health Care, Novartis AG, Bayer AG, Roche Inc, and Others |
Key Segment |
By Scale, End User, Distribution and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
Some of the leading players in the global market include
GlaxoSmithKline Plc., Pfizer, Ranbaxy Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Merck KGaA, Alvizia Health Care, Novartis AG, Bayer AG, Roche Inc, and Others.
This report segments the Varicella virus vaccine market as follows:
By Drug Class Segmentation Analysis
- Quinine
- Chloroquine
- Proguanil
- Mefloquine
- Pyrimethamine
- Others
By Distribution Channel Segmentation Analysis
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Other Distribution Channel
By Regional Segmentation Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
